These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18996767)

  • 1. Selection of electrical algorithms to treat obesity with intermittent vagal block using an implantable medical device.
    Camilleri M; Toouli J; Herrera MF; Kow L; Pantoja JP; Billington CJ; Tweden KS; Wilson RR; Moody FG
    Surg Obes Relat Dis; 2009; 5(2):224-9; discussion 229-30. PubMed ID: 18996767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device.
    Camilleri M; Toouli J; Herrera MF; Kulseng B; Kow L; Pantoja JP; Marvik R; Johnsen G; Billington CJ; Moody FG; Knudson MB; Tweden KS; Vollmer M; Wilson RR; Anvari M
    Surgery; 2008 Jun; 143(6):723-31. PubMed ID: 18549888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesity.
    Sarr MG; Billington CJ; Brancatisano R; Brancatisano A; Toouli J; Kow L; Nguyen NT; Blackstone R; Maher JW; Shikora S; Reeds DN; Eagon JC; Wolfe BM; O'Rourke RW; Fujioka K; Takata M; Swain JM; Morton JM; Ikramuddin S; Schweitzer M; Chand B; Rosenthal R;
    Obes Surg; 2012 Nov; 22(11):1771-82. PubMed ID: 22956251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial.
    Apovian CM; Shah SN; Wolfe BM; Ikramuddin S; Miller CJ; Tweden KS; Billington CJ; Shikora SA
    Obes Surg; 2017 Jan; 27(1):169-176. PubMed ID: 27506803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial.
    Ikramuddin S; Blackstone RP; Brancatisano A; Toouli J; Shah SN; Wolfe BM; Fujioka K; Maher JW; Swain J; Que FG; Morton JM; Leslie DB; Brancatisano R; Kow L; O'Rourke RW; Deveney C; Takata M; Miller CJ; Knudson MB; Tweden KS; Shikora SA; Sarr MG; Billington CJ
    JAMA; 2014 Sep; 312(9):915-22. PubMed ID: 25182100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gastric pacing to treat morbid obesity: two years experience in four patients].
    Salvi PF; Brescia A; Cosenza UM; D'Urso R; Cardelli P; Badiali M
    Ann Ital Chir; 2009; 80(1):25-8. PubMed ID: 19537119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy and safety of sacral nerve stimulation for fecal incontinence.
    Mellgren A; Wexner SD; Coller JA; Devroede G; Lerew DR; Madoff RD; Hull T;
    Dis Colon Rectum; 2011 Sep; 54(9):1065-75. PubMed ID: 21825885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year experience with Tantalus: a new surgical approach to treat morbid obesity.
    Bohdjalian A; Prager G; Aviv R; Policker S; Schindler K; Kretschmer S; Riener R; Zacherl J; Ludvik B
    Obes Surg; 2006 May; 16(5):627-34. PubMed ID: 16687033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of morbid obesity with the Transcend Implantable Gastric Stimulator (IGS): a prospective survey.
    Favretti F; De Luca M; Segato G; Busetto L; Ceoloni A; Magon A; Enzi G
    Obes Surg; 2004 May; 14(5):666-70. PubMed ID: 15186636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revision of vagal nerve stimulator electrodes: technical approach.
    MacDonald J; Couldwell WT
    Acta Neurochir (Wien); 2004 Jun; 146(6):567-70; discussion 570. PubMed ID: 15168224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of Roux limb lengths on outcome after Roux-en-Y gastric bypass: a prospective, randomized clinical trial.
    Choban PS; Flancbaum L
    Obes Surg; 2002 Aug; 12(4):540-5. PubMed ID: 12194548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic intermittent vagal nerve stimulation--a new therapeutic approach in epilepsy].
    Nakken KO; Henriksen O; Røste GK; Lossius R
    Tidsskr Nor Laegeforen; 2001 May; 121(13):1582-5. PubMed ID: 11446042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial.
    Shikora SA; Wolfe BM; Apovian CM; Anvari M; Sarwer DB; Gibbons RD; Ikramuddin S; Miller CJ; Knudson MB; Tweden KS; Sarr MG; Billington CJ
    J Obes; 2015; 2015():365604. PubMed ID: 26246907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International multicenter study of safety and effectiveness of Swedish Adjustable Gastric Band in 1-, 3-, and 5-year follow-up cohorts.
    Toouli J; Kow L; Ramos AC; Aigner F; Pattyn P; Galvão-Neto MP; Miller KA; Romano S; Gutierrez M; Jokinen J
    Surg Obes Relat Dis; 2009; 5(5):598-609. PubMed ID: 19656740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable gastric stimulation for the treatment of clinically severe obesity: results of the SHAPE trial.
    Shikora SA; Bergenstal R; Bessler M; Brody F; Foster G; Frank A; Gold M; Klein S; Kushner R; Sarwer DB
    Surg Obes Relat Dis; 2009; 5(1):31-7. PubMed ID: 19071066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective clinical study of a new implantable peripheral nerve stimulation device to treat chronic pain.
    Deer TR; Levy RM; Rosenfeld EL
    Clin J Pain; 2010 Jun; 26(5):359-72. PubMed ID: 20473041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery.
    Schouten R; Rijs CS; Bouvy ND; Hameeteman W; Koek GH; Janssen IM; Greve JW
    Ann Surg; 2010 Feb; 251(2):236-43. PubMed ID: 19858703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable gastric stimulation to achieve weight loss in patients with a low body mass index: early clinical trial results.
    Champion JK; Williams M; Champion S; Gianos J; Carrasquilla C
    Surg Endosc; 2006 Mar; 20(3):444-7. PubMed ID: 16437276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension.
    Tordoir JH; Scheffers I; Schmidli J; Savolainen H; Liebeskind U; Hansky B; Herold U; Irwin E; Kroon AA; de Leeuw P; Peters TK; Kieval R; Cody R
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):414-21. PubMed ID: 17227715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial.
    Hoppe UC; Brandt MC; Wachter R; Beige J; Rump LC; Kroon AA; Cates AW; Lovett EG; Haller H
    J Am Soc Hypertens; 2012; 6(4):270-6. PubMed ID: 22694986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.